ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Senate Appropriations Committee Slashes NCI Funds By $25 Million

August 18, 1978

Development Of New Screening System For Antimetastasis Drugs Approved

June 25, 1982

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

In Brief: NCAB Appointments: Boutwell Stay On; Brown, Elion, Strong, Korn Named; One Vacancy Remains

May 18, 1984

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

NCI RFP Available.

February 18, 2000